These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 6083957)

  • 1. [Antithrombin III substitution in patients in shock].
    Vinazzer H; Blauhut B; Bergmann H
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(6):806-16. PubMed ID: 6083957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Substitution of antithrombin III in shock patients].
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Anaesthesist; 1982 Jul; 31(7):349-52. PubMed ID: 7125179
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Use of antithrombin III concentrates].
    Vinazzer H
    Beitr Infusionsther; 1989; 24():151-8. PubMed ID: 2481532
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
    Rodríguez Gómez M; López Fernández MF; Batlle J
    Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Substitution of antithrombin III in shock and consumption coagulopathy].
    Blauhut B; Bergmann H; Vinazzer H
    Wien Klin Wochenschr; 1984 Dec; 96(24):879-81. PubMed ID: 6528617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of heparin and/or antithrombin III in a model of disseminated intravascular coagulation induced by endotoxin in rabbits].
    Gómez C; Páramo JA; Rocha E
    Sangre (Barc); 1992 Feb; 37(1):5-10. PubMed ID: 1585238
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Substitution therapy with an antithrombin III concentrate in shock and DIC.
    Blauhut B; Necek S; Vinazzer H; Bergmann H
    Thromb Res; 1982 Aug; 27(3):271-8. PubMed ID: 7135359
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efficacy of antithrombin III in endotoxin-induced disseminated intravascular coagulation.
    Hauptman JG; Hassouna HI; Bell TG; Penner JA; Emerson TE
    Circ Shock; 1988 Jun; 25(2):111-22. PubMed ID: 3390893
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnosis and stage-related treatment of disseminated intravascular coagulation in meningococcal infections.
    Mertens R; Peschgens T; Granzen B; Heimann G
    Klin Padiatr; 1999; 211(2):65-9. PubMed ID: 10407813
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Substitution of antithrombin III.
    Breddin HK; Kirchmaier CM
    Wien Klin Wochenschr; 1984 Dec; 96(24):875-9. PubMed ID: 6528616
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Significance of disordered antithrombin III function in disseminated intravascular coagulation and deep venous thrombosis for anticoagulant therapy].
    von Blohn G; Reiter B; Hellstern P; Wenzel E; Köhler M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1984; 111(4):426-38. PubMed ID: 6083907
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fibrin monomer complexes (SFMC) after substitution of antithrombin III (AT III) in consumption coagulopathy.
    Töpfer G; Ehrhardt W; Dornheim G; Seifert A; Schmidt LH; Senger C; Funke U; Schulze M
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(4):581-5. PubMed ID: 2465977
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in antithrombin III activities by administration method in critical patients with disseminated intravascular coagulation: a pharmacokinetic study.
    Aibiki M; Fukuoka N; Nishiyama T; Maekawa S; Shirakawa Y
    Shock; 2007 Aug; 28(2):141-7. PubMed ID: 17515857
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of early detection and management of disseminated intravascular coagulation among Alexandria University pediatric intensive care patients.
    El-Nawawy A; Abbassy AA; El-Bordiny M; Essawi S
    J Trop Pediatr; 2004 Dec; 50(6):339-47. PubMed ID: 15537719
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Fibrinogen survival and fibrinopeptide A in acute leukemia.
    Castaman G; Galloni E; Dri AV; Rodeghiero F
    Haematologica; 1993; 78(6 Suppl 2):52-6. PubMed ID: 8039760
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Prophylaxis of consumption coagulopathy in shock. Dependence of the effect of heparin on the activity of antithrombin III (author's transl)].
    Bergmann H; Blauhut B; Necek S; Kramar H; Vinazzer H
    Anaesthesist; 1980 Nov; 29(11):623-6. PubMed ID: 7457802
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of hirudin on the consumption of antithrombin III in experimental DIC.
    Hauptmann J; Brüggener E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1988; 115(1-2):83-7. PubMed ID: 2459037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
    Levi M; Toh CH; Thachil J; Watson HG
    Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Treatment of disseminated intravascular coagulation with antithrombin III concentrate in children with verified infection].
    Nowak-Göttl U; Groll A; Kreuz WD; Brand M; Breddin HK; von Loewenich V; Kornhuber B
    Klin Padiatr; 1992; 204(3):134-40. PubMed ID: 1614177
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Anti-coagulant therapy--antithrombin III].
    Tsuji H
    Rinsho Ketsueki; 1990 Jun; 31(6):750-5. PubMed ID: 2214165
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.